In addition to the emphasized morning circadian distribution pattern of stroke frequency, clinical studies support improved functional outcome and recovery in patients who receive thrombolytic therapy during the evening; the morning hypofibrinolytic and hypercoagulable state, in combination with increased PAI-1 levels, may contribute to less effective tPA treatment in the morning. This evidence concerns the gene SERPINE1 and stroke disorder.